Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2005
04/27/2005CN1610694A Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
04/27/2005CN1610693A Transdifferentiation of pancreatic acinar cells
04/27/2005CN1610662A Method of obtaining novel lutein-based formulations
04/27/2005CN1610567A Enhanced systemic absorption of intradermally delivered substances
04/27/2005CN1610564A Compositions and methods of using collajolie
04/27/2005CN1610563A Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments
04/27/2005CN1610559A Prostaglandin composition for the treatment of erectile dysfunction
04/27/2005CN1610555A Eye drops
04/27/2005CN1610551A Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
04/27/2005CN1610550A Pharmaceutical formulations comprising an immune response modifier
04/27/2005CN1610540A Methods and apparatus for improved administration of analgesics
04/27/2005CN1610539A Pharmaceutical composition comprising a 5HT1 receptor agonist
04/27/2005CN1610538A Microemulsion preconcentrate
04/27/2005CN1610507A Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
04/27/2005CN1610506A Center-filled chewing gum containing calcium
04/27/2005CN1609114A Notoginseng leaf total flavone and its prepn and application
04/27/2005CN1608691A Locating and medicating instrument
04/27/2005CN1608674A Compound froctose injection and its medicine use
04/27/2005CN1608670A Refreshing capsule and its prepn process
04/27/2005CN1608669A Filming aerosol for treating tinea coporis, tinea manuum and tinea pedis
04/27/2005CN1608668A Chinese medicine oral powder and plaster for treating rheumatism and rheumatoid disease and their prepn process
04/27/2005CN1608667A Cape jasmine buccal tablet and its prepn process
04/27/2005CN1608664A Medicine and prepn for treating female's climacteric syndrome
04/27/2005CN1608662A Medicine with antiphlogistic, analgetic, microbiostatic and diuretic effects
04/27/2005CN1608661A Capsule prepn for treating women's diseases and its prepn process
04/27/2005CN1608659A Mailuoning injection and its prepn process
04/27/2005CN1608653A Tranquilizing medicine powder for treating hepatic coma
04/27/2005CN1608651A Skin care cosmetic bolus for treating facial acne whelk and chloasma
04/27/2005CN1608650A Chinese medicine for treating coronary heart disease and angina pectoris
04/27/2005CN1608649A Chinese medicine health tonic for raising antisenility capacity and improving memory
04/27/2005CN1608647A Acne treating medicine
04/27/2005CN1608645A Medicine for promoting gastrointestinal function and its prepn process
04/27/2005CN1608642A Composition with function of regulating blood sugar
04/27/2005CN1608641A Food composition with stomach nourishing and protecting function and its prepn process
04/27/2005CN1608639A Chinese angelica dripping pill and its prepn process
04/27/2005CN1608638A Blood cleaning metabolism bolus
04/27/2005CN1608629A Compound panoxatriol saponin with physiological activity and its prepn and use
04/27/2005CN1608626A Fosphenytoin sodium powder for injection and its prepn
04/27/2005CN1608624A Cefpoxime proxetil for clinical injection
04/27/2005CN1608623A Enteric coated donepezil hydrochloride tablet and its perpn process
04/27/2005CN1608622A Solid dispersed Nimoldipine tablet and its prepn process
04/27/2005CN1608621A Fine bicyclic alcohol powder and oral bicyclic alcohol release controlling prepn
04/27/2005CN1608620A Solid bicyclic alcohol dispersion
04/27/2005CN1608618A Veterinary medicine injection containing chlorocyaniosaliamine or its sodium salt
04/27/2005CN1608617A Application of levocarnitine and its derivative in preventing and treating high altitude diseases
04/27/2005CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process
04/27/2005CN1608614A New slimming effervescent tablet form
04/27/2005CN1608613A Fibrauretine powder for injection and its production process
04/27/2005CN1608519A Health care food
04/27/2005CN1198844C Process of high purity albumin production
04/27/2005CN1198824C Polymorphs of N-methyl-N-(3-3-{2-thienylcarbonyl]-pyrazol -[1,5-alpha]-pyrimidin-7-yl}phenyl)a cetamide and compositions and methods related thereton
04/27/2005CN1198659C Medical preparation, its preparing method and use in preparing medicine for accelerating collagen regeneration
04/27/2005CN1198655C Solid mixtures of cyclodextrins prep. via melt-extrusion
04/27/2005CN1198654C Pharmaceutical complex
04/27/2005CN1198653C Preparations for preventing bile acid diarrhea
04/27/2005CN1198652C Method for adding activated medicinal compounds into foundamental materials
04/27/2005CN1198650C Ocular tension lowering composition for topical administration
04/27/2005CN1198644C Human parathyroid hormone medicine composition
04/27/2005CN1198643C Insulin preparations containing carbohydrates
04/27/2005CN1198632C Distillate of medicinal herbs for treating skin disease
04/27/2005CN1198628C Conditioned cell culture medium compositions and method of use
04/27/2005CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome
04/27/2005CN1198623C Ciclesonide-containing aqueous pharmaceutical composition
04/27/2005CN1198621C Adhesive preparation containing estradiol
04/27/2005CN1198616C Oral formulations for anti-tumor compounds
04/27/2005CN1198615C Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates
04/27/2005CN1198611C Anti-bacterial medicinal compositions
04/27/2005CN1198609C Use of taxiol stabilized by albumin in preparing medicine for treating body tumor and medicine obtained therefrom
04/27/2005CN1198603C Spray liquid for forming bandage and drug delivery system
04/27/2005CN1198602C Osmotic delivery system with semipermeable plug
04/27/2005CN1198601C Osmotic delivery system flow modulator appts.
04/27/2005CN1198600C Edible MCC/PGA coating composition
04/27/2005CN1198599C Long time drug-sustained release preparation
04/27/2005CN1198598C Hydrophilic/lipophilic polymeric matrix dosage
04/27/2005CN1198597C Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor
04/27/2005CN1198596C Sustained release formulations for 24 hours release of metoprolol
04/27/2005CN1198595C Process for preparation of spraying granule of ovoflaving
04/27/2005CN1198594C Therapeutically active compositions
04/27/2005CN1198593C Supercritical fluid-assisted nebulization and bubble drying
04/27/2005CN1198592C Process for producing particles with converted amorphous and/or meta-stable drystalline region into crystalline state
04/27/2005CN1198591C Bioenhanced formulations comprising eprosartan in oral dosage form
04/27/2005CN1198590C Antibody and polyalkylene glycol-bonded liposome
04/27/2005CN1198589C Method for controlling liposome size
04/27/2005CN1198588C Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it
04/27/2005CN1198587C Tear-gland specific emulsion for local application to eye tissue
04/27/2005CN1198586C Topical compositions for NSAI drug delivery
04/27/2005CN1198585C Effervescent ointment for vagina and rectum administration and its prepn
04/27/2005CN1198584C Dosage forms having a barrier layer to laser ablation
04/27/2005CN1198583C Milling process for production of finely milled medicinal substances
04/27/2005CN1198582C Microparticle formulation for inhalation
04/27/2005CN1198563C Acidified composition for topical treatment of nail and skin conditions
04/27/2005CN1198518C Composition comprising liquid absorbed on support based on precipitate silica
04/26/2005US6884882 Introducing an acetylene group at the 5-position of 2'-deoxyuridine, and reacting the formed intermediate 2'-deoxyuridine having the acetylene group at the 5-position, with a benzyl azide derivative
04/26/2005US6884804 Inhibitors of Src and other protein kinases
04/26/2005US6884794 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
04/26/2005US6884792 Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
04/26/2005US6884790 Verifiable absorption drug delivery form based on cyclodextrins
04/26/2005US6884768 Using taurine compound; adjust bioavailability; prevent, suppression damage to intestine mucous membrane
04/26/2005US6884438 Encapsulation of a drug by nanocapsules being dispersible in aqueous phase in colloidal form, nontoxic, biocompatible, stable in colloidal suspension and economical and prepared using two non-oily solvents and an oily solvent; time-release
04/26/2005US6884437 Administration form comprising an acid-labile active compound